Carl Zeiss Meditec (AFX.DE) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN DE0005313704
Carl Zeiss Meditec financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.07 bn EUR | 2.23 bn EUR |
| Gross profit | 1.09 bn EUR | 1.18 bn EUR |
| Operating income | 177.21 m EUR | 223.30 m EUR |
| EBIT | 194.00 m EUR | 223.00 m EUR |
| Net income | 178.00 m EUR | 141.00 m EUR |
| Diluted EPS – continuing operations | 2.05 EUR | 1.73 EUR |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company has a strategic collaboration with Envision Health Technologies Inc. to help advance glaucoma care through gamified virtual reality technology. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
More stocks
- SEB SA (SK.PA)
- Cipher Digital Inc. (CIFR)
- ACADIA PHARMACEUTICALS INC (ACAD)
- Sendas Distribuidora S.A. (ASAI3.SA)
- BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM)
- Antar Chile (ANTARCHILE.SN)
- CIE Automotive SA (CIE.MC)
- Simcere Pharmaceutical Group Ltd (2096.HK)
- Yamaha Corp (7951.T)
- Multiplan Empreendimentos Imobiliários S.A (MULT3.SA)
- China Gas Holdings Ltd (384.HK)
- LEENO Industrial Inc (058470.KQ)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.